Ossium Health Receives $3.46 Million in Funding

The California Institute of Regenerative Medicine CIRM has awarded Ossium Health, Inc. a $3.46M Clinical Stage Research Program CLIN1 grant to support the continued clinical development of OSSM-007, Ossium’s interferon-gamma primed mesenchymal stem cell product, for the treatment of steroid-refractory acute graft versus host disease (GVHD). This investment will assist and accelerate pre-clinical and manufacturing … Read more

RISE, The Mom Project’s non-profit upskilling program, provides graduates with annual total salary increases totaling more than $17 million

The Mom Project, a leading digital talent and community platform serving over one million moms and 3,000+ businesses, and RISE, its 501(c) 3 upskilling program for women and moms of color, released their annual RISE 2022 Impact Report, highlighting that the program has delivered over $17 million in first-year aggregate total salary increase for its … Read more

XTM Inc. Announces Up to $5,000,000 in Convertible Debenture Financing

XTM Inc. XTM or the Company a Miami and Toronto-based Fintech creator of disruptive payment innovations specifically for service industries such as hospitality, personal care, and service staff, today announced the Company intends to complete a non-brokered private placement of convertible debentures of the Company each, a “Convertible Debenture Units at Each Convertible Debenture Unit … Read more

Seres Therapeutics Announces $250 Million Debt Financing with Oaktree Capital Management

Seres Therapeutics, Inc.  a leading microbiome therapeutics firm, said today that it has entered into a new $250 million senior secured loan facility  Term Loan Facility financed by Oaktree Capital Management, L.P. Oaktree . At closing, the Company received the first tranche of $110 million, with three additional tranches available. These additional tranches include $90 … Read more

Therini Bio secures $36 million in Series A funding to develop fibrin-targeted therapies for neurodegenerative and retinal diseases

Therini Bio secures  million in Series A funding to develop fibrin-targeted therapies for neurodegenerative and retinal diseases

Therini Bio Inc., a biotech firm focused on creating fibrin-targeted treatments to treat inflammatory neurological and retinal diseases, announced today the completion of a $36 million Series A fundraising transaction. The fundraising round was headed by Dementia Discovery Fund, MRL Ventures Fund, Merck & Co., Inc.’s therapeutics-focused corporate venture fund, Sanofi Ventures, and SV Health … Read more

ODDITY invests $100 million to bring AI-based molecule discovery technology from pharmaceuticals to the beauty and wellness industries

ODDITY, the consumer technology platform designed to transform the global beauty and wellness market, today announced the $76 million acquisition of Boston-based Revela, an industry-leading biotechnology startup and pioneer in AI-based molecule discovery for beauty and wellness indications. With the acquisition, the company will open ODDITY LABS in Boston and invest an extra $25 million … Read more

LTK Celebrates the First Anniversary of LTK Connect with a $2 Million Investment in Platform Brands

LTK, the global creator marketing platform, has reached a key milestone in commemorating the first anniversary of its award-winning self-serve marketing platform, LTK Connect. In less than a year, LTK Connect has linked 1,000 direct-to-consumer companies into the ecommerce platform, giving them instant access to premium lifestyle producers and allowing them to effortlessly design and … Read more

Pinecone Raises $100 Million in Series B funding to provide AI with long-term memory

Pinecone, a vector database startup that provides long-term memory for AI, revealed today that it has raised $100 million in Series B funding at a valuation of $750 million. Andreessen Horowitz led the round, with participation from ICONIQ Growth and prior investors Menlo Ventures and Wing Venture Capital. Pinecone’s revolutionary technology and exponential growth have … Read more

Imagia Raises $4.5 Million to Explore New Optoelectronic Frontiers

Imagia Raises .5 Million to Explore New Optoelectronic Frontiers

Imagia, a developer of next-generation lens technology, announced today the completion of a $4.5 million seed investment. The funding, led by Gates Frontier and joined by MetaVC Partners and other strategic investors, will speed up the development and commercialization of the company’s first generation of flat, silicon-based optical lenses. Imagia’s metalens technology can compress an … Read more

Lasso MD raises $2 million to assist dentists in expanding their patient base

Lasso MD raises $2 million to assist dentists in expanding their patient base. Lasso MD, the premier all-in-one marketing solution for dental and medspa practices, announced today a $2M lead investment from Trestle Partners (“Trestle”), a New York-based private investment firm with extensive experience collaborating with SaaS and Martech startups. Lasso MD is essentially a … Read more